In a statement, Dr. med Thomas Huth shares his experiences and findings with regard to the positive influence of FaceFormer therapy on the diabetic metabolic status of patients with type 2 diabetes mellitus.
On the positive effect of the FaceFormer on diabetic metabolism situation
Patients treated with Faceformer therapy for swallowing disorders and sleep apnea syndrome, and which were besides diagnosed with type 2 diabetes mellitus, not only showed significant improvements in their swallowing and breathing but also a positive effect on the type Diabetic metabolic system. Blood glucose levels and the long-term value of HbA1-c improved by 10-15% as part of FaceFormer treatment. They were able to reduce or even completely omit their medication.Thus, the question arises, could FaceFormer therapy be a complementary therapeutical option for the treatment of a diabetes patient, support or even replace a drug therapy with antidiabetics? This observed positive effect of the faceformer on the sugar metabolism could be hypothetically explained as follows: The faceformer therapy has a stimulating effect on the inner pharyngeal musculature and the corresponding nerve structures. An activation of the vagus nerve occurs, which has an activating effect on the gastrointestinal musculature and its mucous membranes.
According to latest knowledge, the secretion of Incretin in the small intestine mucous membrane has a distinct impact on the glucose metabolism. Incretins, which are reactively released after a meal in the small intestine, have an anti-diabetic effect. According to this principle of action, the gliptins, DPP4 inhibitors, are successfully applied nowadays.
The incretins have a stimulating effect on the pancreatic beta cells, leading to an increased release of insulin and consequently to a blood glucose suppression. In addition, an effect of the incretins on the alpha cells of the pancreas was detected, whereby a reduction of the gluconeogenesis with reduction of the glucose formation takes place. Furthermore, an improvement in the diabetic metabolic position is given by an increased uptake of the glucose into the cell and its metabolism.
In summary, it can be said that the FaceFormer provokes an increase in the incretin output via the intraoral stimulation of the vagus nerve. This results in increased insulin formation, reduction in gluconeogenesis, improvement in the introduction of the sugar into the cell and thus in a marked reduction in blood glucose.
The positive effect of the faceformer on the diabetes metabolism is an experience-based finding, which should definitely be confirmed by scientific studies.
Dr. med. Thomas Huth
Fröndenberg, 13. september 2014